Thalys(SH:603716) Zheng Xing Xing Ye Ri Bao·2025-09-09 08:39Market Overview - The pharmaceutical commercial sector experienced a decline of 0.45% on September 9, with Saily Medical leading the drop [1] - The Shanghai Composite Index closed at 3807.29, down 0.51%, while the Shenzhen Component Index closed at 12510.6, down 1.23% [1] Stock Performance - The top performer in the pharmaceutical sector was Baiyang Pharmaceutical, which saw a closing price of 31.03 with a gain of 6.67% and a trading volume of 166,100 shares, amounting to 505 million yuan [1] - Saily Medical had a significant decline, closing at 27.60 with a drop of 4.13% and a trading volume of 216,000 shares, totaling 609 million yuan [2] - Other notable stocks included Yingtai Group, which rose by 0.77%, and Dacelin, which saw a minor increase of 0.11% [1] Capital Flow - The pharmaceutical commercial sector saw a net outflow of 215 million yuan from institutional investors, while retail investors contributed a net inflow of 168 million yuan [2] - The data indicates that retail investors were more active in the market compared to institutional investors, as evidenced by the net inflow figures [2] Individual Stock Capital Flow - Baiyang Pharmaceutical had a net inflow of 26.03 million yuan from institutional investors, while it experienced a net outflow of 17.86 million yuan from retail investors [3] - Nanjing Pharmaceutical saw a net inflow of 7.48 million yuan from institutional investors, but a net outflow of 6.85 million yuan from retail investors [3] - The overall trend shows that while some stocks attracted institutional interest, others faced selling pressure from retail investors [3]